Kopran Limited (BOM:524280)
India · Delayed Price · Currency is INR 284.85
+13.60 (5.01%)
At close: Sep 25, 2026
Kopran Market Cap
Kopran has a market cap or net worth of 13.75 billion as of September 25, 2026. Its market cap has increased by 55.83% in one year.
Market Cap
13.75B
Enterprise Value
15.27B
Revenue
7.00B
Ranking
n/a
PE Ratio
55.06
Stock Price
284.85
ChartMarket Cap Chart
Since April 1, 2002, Kopran's market cap has increased from 572.00M to 13.75B, an increase of 2,304.57%. That is a compound annual growth rate of 13.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 13.75B | 90.03% |
| Dec 31, 2025 | 7.24B | -29.34% |
| Dec 31, 2024 | 10.24B | -11.98% |
| Dec 29, 2023 | 11.64B | 60.08% |
| Dec 30, 2022 | 7.27B | -48.06% |
| Dec 31, 2021 | 14.00B | 132.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Fredun Pharmaceuticals | 22.50B |
| Venus Remedies | 21.74B |
| Syncom Formulations (India) | 18.88B |
| TTK Healthcare | 14.82B |
| Amrutanjan Health Care | 14.77B |
| Fermenta Biotech | 13.80B |
| Lincoln Pharmaceuticals | 11.93B |
| Bharat Parenterals | 10.88B |